Cato Research Ltd., a global contract research and development organization, today announced that it has named Dr. Erik Berglund as its new Associate Managing Director of its San Francisco office.
Dr. Berglund most recently served as Associate Managing Director of Cato Research’s San Diego location prior to accepting the position in San Francisco. Dr. Berglund has over 20 years’ experience in the research and development industry, including nearly 10 years’ experience in regulatory affairs and clinical development at Cato Research.
“Dr Berglund brings great leadership experience to our San Francisco office” said Jo Cato, Ph.D., Managing Director, Cato Research – San Francisco. “Dr. Berglund’s knowledge and motivation for helping pharmaceutical and biotechnology companies bring new drugs to market efficiently and cost-effectively complement the strategic vision of our organization. I look forward to his leadership and his assistance to our growing office.”
About Cato Research Ltd.
Founded in 1988 by Dr. Allen Cato and Lynda Sutton and headquartered near Research Triangle Park, North Carolina, Cato Research is a privately owned, full-service, global contract research organization providing strategic and tactical support for companies in the pharmaceutical, biotechnology, medical device, and medical diagnostic industries. With a staff of more than 200 employees located in the United States, Europe, Canada, Israel, and South Africa, Cato Research’s services range from design and management of preclinical and clinical studies to submission of regulatory documents required for marketing approval.
